Drug Patent Expirations in September 2008

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in September 2008
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

ANDRODERM
Watson Labs
testosterone
4,855,294
Sep 6, 2008

AVITA
Mylan Bertek
tretinoin
5,045,317
Sep 3, 2008

DDAVP
Sanofi Aventis Us
desmopressin acetate
5,047,398
Sep 10, 2008

OPANA ER
Endo Pharms
oxymorphone hydrochloride
5,128,143
Sep 19, 2008

RESCULA
R Tech Ueno Ltd
unoprostone isopropyl
5,001,153
Sep 19, 2008

Courtesy of DrugPatentWatch.com

Contract research helps keep drug pipeline flowing

Guest content from Turner Investment Partners‘ Heather Flick McMeekin, Frank Sustersic, Vijay Shankaran, and Theresa Hoang:
Contract research helps keep drug pipeline flowing
Imagine a new-product development process that typically lasts 10 to 15 years, has only a one in 5,000 chance of succeeding, and costs at least $800 million. That’s the daunting reality that biopharmaceutical companies [...]

Building Biotechnology 3rd Edition now available

460 pages
Hardcover:978-09734676-5-9
Hardcover:978-09734676-6-6
Third Edition
August, 2008
Homepage
Building Biotechnology

Business, Regulations, Patents, Law, Politics, Science
The definitive primer and leading textbook on the business of biotechnology is now available in its third edition. This new edition is over 100 pages longer than the second edition and adds new chapters, new figures and tables, and additional case examples.
Building Biotechnology [...]

Beyond the Business Plan: Managing unexpected risk in biotechnology business development

Here’s a slideshow of a talk I recently gave at the Johns Hopkins biotechnology MS/MBA program. The purpose is to illustrate the elements which are important to consider after penning your business plan, and to help position oneself to be prepared for unexpected risks.
The material is largely drawn from my book, Building Biotechnology. Go ahead [...]

Drug Patent Expirations in August 2008

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in August 2008
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

ADVAIR DISKUS 100/50
Glaxosmithkline
fluticasone propionate; salmeterol xinafoate
4,992,474
Aug 12, 2008

ADVAIR DISKUS 100/50
Glaxosmithkline
fluticasone propionate; salmeterol xinafoate
5,126,375
Aug 12, 2008

ADVAIR DISKUS 100/50
Glaxosmithkline
fluticasone propionate; salmeterol xinafoate
5,225,445
Aug 12, 2008

ADVAIR DISKUS 250/50
Glaxosmithkline
fluticasone propionate; salmeterol xinafoate
4,992,474
Aug 12, 2008

ADVAIR DISKUS 250/50
Glaxosmithkline
fluticasone propionate; salmeterol xinafoate
5,126,375
Aug 12, 2008

ADVAIR DISKUS 250/50
Glaxosmithkline
fluticasone propionate; [...]

Roche and Genentech’s mating dance — This isn’t the first time

Roche has floated an offer to acquire Genentech, a move which has raised a flurry of questions about the sustainability of the big Pharma business model, Genentech’s future independence, and the value of Genentech. It it worth noting, however, that Roche already bought (and sold) Genentech. Using an excerpt from Building Biotechnology to illustrate, Roche [...]